244
Participants
Start Date
February 29, 2008
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
insulin detemir
Treat-to-target dose titration scheme, s.c. injection, once daily. Fasting plasma glucose (FPG) titration target range of 70-90 mg/dL
insulin detemir
Treat-to-target dose titration scheme, s.c. injection, once daily. Fasting plasma glucose (FPG) titration target range of 80-110 mg/dL
Novo Nordisk Investigational Site, New York
Novo Nordisk Investigational Site, Staten Island
Novo Nordisk Investigational Site, West Seneca
Novo Nordisk Investigational Site, Altoona
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Norristown
Novo Nordisk Investigational Site, Shelby
Novo Nordisk Investigational Site, Statesville
Novo Nordisk Investigational Site, Spartanburg
Novo Nordisk Investigational Site, Taylors
Novo Nordisk Investigational Site, Roswell
Novo Nordisk Investigational Site, Athens
Novo Nordisk Investigational Site, Savannah
Novo Nordisk Investigational Site, Jacksonville
Novo Nordisk Investigational Site, Jacksonville
Novo Nordisk Investigational Site, Jacksonville
Novo Nordisk Investigational Site, Lake Mary
Novo Nordisk Investigational Site, Plantation
Novo Nordisk Investigational Site, Boca Raton
Novo Nordisk Investigational Site, Chattanooga
Novo Nordisk Investigational Site, Chattanooga
Novo Nordisk Investigational Site, Mentor
Novo Nordisk Investigational Site, Cincinnati
Novo Nordisk Investigational Site, Dayton
Novo Nordisk Investigational Site, Dayton
Novo Nordisk Investigational Site, Terre Haute
Novo Nordisk Investigational Site, Milwaukee
Novo Nordisk Investigational Site, Saint Paul
Novo Nordisk Investigational Site, Chicago
Novo Nordisk Investigational Site, St Louis
Novo Nordisk Investigational Site, Topeka
Novo Nordisk Investigational Site, Omaha
Novo Nordisk Investigational Site, New Orleans
Novo Nordisk Investigational Site, Searcy
Novo Nordisk Investigational Site, Oklahoma City
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Arlington
Novo Nordisk Investigational Site, Houston
Novo Nordisk Investigational Site, Houston
Novo Nordisk Investigational Site, San Antonio
Novo Nordisk Investigational Site, Midland
Novo Nordisk Investigational Site, Odessa
Novo Nordisk Investigational Site, Goodyear
Novo Nordisk Investigational Site, Las Vegas
Novo Nordisk Investigational Site, Los Angeles
Novo Nordisk Investigational Site, Los Angeles
Novo Nordisk Investigational Site, Artesia
Novo Nordisk Investigational Site, Spring Valley
Novo Nordisk Investigational Site, Escondido
Novo Nordisk Investigational Site, Orange
Novo Nordisk Investigational Site, Walnut Creek
Novo Nordisk Investigational Site, Spokane
Novo Nordisk Investigational Site, Scottsdale
Novo Nordisk Investigational Site, Fullerton
Novo Nordisk Investigational Site, Parker
Novo Nordisk Investigational Site, Norwalk
Novo Nordisk Investigational Site, Prospect
Novo Nordisk Investigational Site, Clearwater
Novo Nordisk Investigational Site, Idaho Falls
Novo Nordisk Investigational Site, Pikesville
Novo Nordisk Investigational Site, Chesterfield
Novo Nordisk Investigational Site, Berlin
Novo Nordisk Investigational Site, Camden
Novo Nordisk Investigational Site, Lawrenceville
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Spokane
Novo Nordisk Investigational Site, Caguas
Novo Nordisk Investigational Site, San Juan
Novo Nordisk Investigational Site, Trujillo Alto
Lead Sponsor
Novo Nordisk A/S
INDUSTRY